Regenerative Approaches to Post-Myocardial Infarction Heart Failure

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|12|1930-1940

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.12, 2014-04, pp. : 1930-1940

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure

By Croom Katherine F.   Plosker Greg L.  

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1057-1072

Adis International

Access to resources Recommend Favorite

The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction population

By Benge Cassandra D   Muldowney James A S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1469-1482

Informa Healthcare

Access to resources Recommend Favorite

Calcium Antagonists in the Post-Myocardial Infarction Setting

By Bertolet B.D.  

Drugs & Aging, Vol. 15, Iss. 6, 1999-12 ,pp. : 461-470

Adis International

Access to resources Recommend Favorite

Underutilization of -Adrenoceptor Antagonists Post-Myocardial Infarction

By Gutierrez Michael E.   Labovitz Arthur J.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 23-29

Adis International

Access to resources Recommend Favorite

Fibrosis as a Therapeutic Target Post-Myocardial Infarction

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 477-487

Bentham Science Publishers

Access to resources Recommend Favorite